Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Alexion Continues Pipeline Rebuilding With $400m Takeout Of Syntimmune

Sep 26 2018

• By Joseph Haas

3-D Rendering Red Blood Cells

Additional Topics

Deals Rare Diseases Commercial Business Strategies M & A BioPharmaceutical Blood & Coagulation Disorders Immune Disorders

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window